Driehaus Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Driehaus Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-12,026	Closed	-$1.35M	–	492
2014 Q4	$1.35M	Sell	12,026 -159,581	-93%	-$14.2M	0.05%	369
2014 Q3	$10.5M	Sell	171,607 -84,654	-33%	-$3.65M	0.4%	53
2014 Q2	$11.7M	Sell	256,261 -9,898	-4%	-$403K	0.38%	50
2014 Q1	$10.4M	Buy	266,159 +12,977	+5%	+$434K	0.33%	72
2013 Q4	$6.06M	Sell	253,182 -4,789	-2%	-$109K	0.22%	143
2013 Q3	$7.21M	Buy	+257,971	New	+$7.12M	0.28%	116

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CGT

Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Driehaus Capital Management's AGIO Position: Q1 2015 in Review

Driehaus Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2015, closing a stake of 12,026 shares — an estimated $1.35M sold.

Driehaus Capital Management first reported a position in AGIO in Q3 2013 and held it in 6 quarters. The position peaked at $11.7M in Q2 2014. 152 funds tracked by Wall St. Rank hold AGIO as of Q1 2015.

Driehaus Capital Management reported no remaining Agios Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Driehaus Capital Management sold 12,026 Agios Pharmaceuticals shares in Q1 2015, an estimated $1.35M.
Driehaus Capital Management first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 6 quarters.
Driehaus Capital Management's Agios Pharmaceuticals position peaked at $11.7M in Q2 2014.
152 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2015.

Based on Driehaus Capital Management's 13F filing for Q1 2015, filed 15 May 2015.